Company Filing History:
Years Active: 1996-1997
Title: Venkatraghaven Vasudevan: Innovator in Pharmaceutical Formulations
Introduction
Venkatraghaven Vasudevan is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antifungal agents and angiotensin II antagonists. With a total of 2 patents, his work has the potential to impact medical treatments significantly.
Latest Patents
Vasudevan's latest patents include innovative pharmaceutical formulations. One of his notable inventions is related to cyclic peptide antifungal agents, which provide methods for inhibiting fungal and parasitic activity using specific compounds. Another significant patent focuses on angiotensin II antagonist intermediates, offering novel heterocyclic derivatives and their pharmaceutical applications for antagonizing angiotensin II receptors in mammals.
Career Highlights
Vasudevan is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation in healthcare. His work at Eli Lilly has allowed him to explore and develop groundbreaking solutions in the pharmaceutical industry.
Collaborations
Throughout his career, Vasudevan has collaborated with esteemed colleagues, including Peter S. Borromeo and James Andrew Jamison. These collaborations have fostered an environment of innovation and creativity, contributing to the advancement of pharmaceutical science.
Conclusion
Venkatraghaven Vasudevan's contributions to pharmaceutical formulations demonstrate his commitment to innovation and improving healthcare solutions. His patents reflect a deep understanding of complex biological interactions and a dedication to developing effective treatments.